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0022-2836/© 2009 Elsevier Ltd. Open accRelB, the ribbon–helix–helix (RHH) repressor encoded by the relBE toxin–
antitoxin locus of Escherichia coli, interacts with RelE and thereby counter-
acts the mRNA cleavage activity of RelE. In addition, RelB dimers repress
the strong relBE promoter and this repression by RelB is enhanced by RelE;
that is, RelE functions as a transcriptional co-repressor. RelB is a Lon
protease substrate, and Lon is required both for activation of relBE
transcription and for activation of the mRNA cleavage activity of RelE.
Here we characterize the molecular interactions important for transcrip-
tional control of the relBE model operon. Using an in vivo screen for relB
mutants, we identified multiple nucleotide changes that map to important
amino acid positions within the DNA-binding domain formed by the N-
terminal RHH motif of RelB. Analysis of DNA binding of a subset of these
mutant RHH proteins by gel-shift assays, transcriptional fusion assays and
a structure model of RelB–DNA revealed amino acid residues making
crucial DNA–backbone contacts within the operator (relO) DNA. Muta-
tional and footprinting analyses of relO showed that RelB dimers bind on
the same face of the DNA helix and that the RHHmotif recognizes four 6-bp
repeats within the bipartite binding site. The spacing between each half-site
was found to be essential for cooperative interactions between adjacently
bound RelB dimers stabilized by the co-repressor RelE. Kinetic and
stoichiometric measurements of the interaction between RelB and RelE
confirmed that the proteins form a high-affinity complex with a 2:1
stoichiometry. Lon degraded RelB in vitro and degradation was inhibited by
RelE, consistent with the proposal that RelE protects RelB from proteolysis
by Lon in vivo.© 2009 Elsevier Ltd. Open access under CC BY license.Edited by R. Ebright Keywords: toxin; antitoxin; RelB; RelE; ribbon–helix–helixIntroduction
Toxin–antitoxin (TA) loci are abundant gene
cassettes present, often in multiple copies, on
plasmids and chromosomes of Bacteria and
Archaea.1 TA loci encode a stable “toxin” that
inhibits translation or replication and an unstableress:
–helix–helix; TA,
, surface plasmon
se; X-gal, 5-bromo-4-
TA,
ess under CC BY license.antitoxin that neutralizes the toxin. Ectopic produc-
tion of the toxins is highly inhibitory to cell growth,
but the antitoxins form complexes with the toxins
and thereby counterbalance toxin activity. Activa-
tion of TA loci depends on cellular proteases such as
Lon or Clp that degrade the antitoxins.2,3
Two major classes of toxins have been identified
based on their cellular targets. One class of toxins
inhibits translation by mRNA cleavage (i.e., RelE
and MazF) and is commonly referred to as mRNA
interferases.4–8 Another class of toxins inhibits DNA
gyrase and thereby inhibits replication (i.e., CcdB
and ParE).9–11 The antitoxins are small modular
proteins that contain an N-terminal structured
DNA-binding domain, required for autoregulation
of TA operon transcription, and a flexible C-
terminus, required for antitoxin activity.12–15 Upon
184 Regulatory Interactions of RelBinteraction with the cognate toxin, the C-terminus of
the antitoxin becomes structured and results in the
formation of a tight nontoxic protein complex.16–18
In almost all cases known, the TA complex binds to
one or more operators in the TA promoter region
and represses transcription of the TA operon.19–21 In
its free state, the antitoxin is degraded by one or
more cellular proteases.2,3,22–26 Thus, the cellular
levels and turnover rates of the proteins are adjusted
by a combination of autoregulation and proteolysis.
Usually, the TA genes are translationally coupled
and produce antitoxin in excess of the toxin,
ensuring efficient inactivation of the latter,27, 28, 29
although exceptions to this paradigm probably
exist.8
The relBE locus of Escherichia coli encodes mRNA
interferase RelE that cleaves mRNA positioned at
the ribosomal A-site and antitoxin RelB that counter-
acts this activity.5,30 RelB copurifies with RelE and
the proteins interact in the yeast two-hybrid
system.31,32 The relBE operon is autoregulated by
RelB, which alone functions as a repressor of
transcription. The RelBE complex represses tran-
scription more efficiently than RelB alone; thus, RelE
functions as a co-repressor of transcription.19,33,34
During steady-state cell growth, relBE transcription
is efficiently repressed due to autoregulation by the
RelBE complex.2,19,33 By contrast, conditions that
inhibit translation, such as amino acid starvation,
induce relBE transcription and concomitantly acti-
vate RelE.2,19,35,36 The metabolic turnover of RelB
depends on Lon protease and degradation of RelB
was suggested to explain the strongly increased
relBE transcription during amino acid starvation.2
Recently, we showed that RelB and RelE form a tight
RelB2·RelE complex that bound cooperatively to the
relO operator in the relBE promoter region.33
Interestingly, relBE transcription was controlled by
the RelB/RelE ratio rather than the absolute
amounts of the proteins. Thus, with excess RelB,
RelE strongly enhanced binding of RelB to the
operator and repressed transcription. By contrast,
excess RelE prevented RelB binding to relO in vitro
and stimulated relBE operon transcription in vivo.
Thus, excess RelE triggered relBE transcription.
The solution structure of a RelB dimer was
obtained recently.34 Consistent with our findings,33
this study showed that a RelB dimer recognizes a
hexad repeat in the palindromic operator through
an N-terminal ribbon–helix–helix (RHH) motif and
that RelE enhances the affinity of adjacent bound
RelB dimers for the operator element. Moreover, it
was demonstrated that the flexible C-terminus of
RelB is required for RelB dimers to dimerize.
To gain further insight into the molecular interac-
tions controlling the relBE transcription and RelE
activity, we have undertaken a genetic and bio-
chemical study of the regulatory properties of RelB.
Using an in vivo screen for relB mutants defective
in autoregulation, we identify amino acid residues
within the RHH motif of RelB important for DNA
binding. By mutational analysis of relO and hydroxyl
radical footprinting, we show that RelB occupiesfour hexad repeats within relO with the core
sequence [A/T]TGT[A/C]A. By nucleotide inser-
tions, we show that no spacing is allowed between
each of the two relO half-sites in order for the
repression complex to maintain autoregulation. The
appearance of free RelE is prevented by tight
subnanomolar interaction to RelB and an ∼10-fold
lower in vivo concentration to that of its cognate
antitoxin. The ATP-dependent Lon protease binds to
RelB and stimulates its degradation. Together, these
results provide a quantitative and mechanistic basis
for how the activity of the model RelE mRNA
interferase is controlled.Results
Random mutagenesis of relB
To identify amino acid residues in RelB important
for autoregulation of the relBE operon, we con-
structed an in vivo screen based on a plasmid
(pMO2541) in which the relBER81A operon was
fused in-frame to lacZ (Fig. 1a); relER81A encodes a
nontoxic version of RelE.31 In keeping with our
previous finding that RelB autoregulates relBE
transcription,19,33 this plasmid (pMO2541) expressed
a very low level of LacZ activity in a ΔrelBE deletion
strain (b1 U, data not shown). Since RelE is required
for efficient autorepression, this low level of LacZ
activity indicated that the LacZ portion of the RelE::
LacZ fusion protein did not interfere with the co-
repressor function of RelE.
Using silent mutations, we engineered two restric-
tion sites into either end of relB, thus being able to
insert relB-encoding DNA fragments that had been
mutagenized by PCR into the natural context of relB
(codons 4–76). Next, we screened for mutant alleles
yielding dark blue colonies on X-gal (5-bromo-4-
chloro-3-indoyl-β-D-galactoside) indicator plates. As
expected, most such mutations were located in the
RHH motif of RelB (Fig. 1b, vertical arrows). Some
mutations (base transversions or transitions) were
found together with one of the other mutations
(Fig. 1b, residues colored black), while most mutant
alleles (residues colored red) only contained single
base mutations. We did not observe any mutations
leading to substitutions in the conserved signature
residue R7 of RelB; however, mutations were found
encoding residues specific for the RelB family (I8, D9
and K13) (Fig. 1b) and also in the conserved residues
S28, R32 and L33. Interestingly, we also obtained the
relB101 allele A39D that leads to “hyperactivation”
of RelE due to metabolic instability of RelBA39D (Ref.
23). The relB101 mutation was originally found in a
genetic screen that identified mutations that ren-
dered the cell unable to inhibit synthesis of stable
RNA during amino acid starvation,38 the so-called
delayed relaxed response.
To map our mutations on the RelB structure, we
constructed a model of (RelB2)2–DNA based on
the previous published NMR structure of the RelB
Fig. 1. RelB mutants defective in transcriptional autoregulation. (a) Schematic of pMO2541 carrying a translational
relBER81A::lacZ fusion used to insert mutagenic PCR fragments of relB in order to screen for derepressed (blue) mutant
colonies on X-gal indicator plates. (b) Multiple alignment of the RHHmotifs of RelB, E. coli; RelB, R. leguminosarum; RelB2
(DinJ), E. coli; FitA, N. gonorrhoeae; and Arc, bacteriophage P22. Residues are marked by decreasing conservation: white
text on black boxes; white text on dark grey boxes and black text on grey boxes. Vertical arrows indicate the amino acid
substitutions that were found in the RelB RHH variants obtained in the screen. Amino acids shown in black were obtained
in combination with one of the other mutations, whereas amino acids colored in red were obtained independently in each
clone. The aspartate colored in blue is encoded by the previously described relB101 allele. Amino acids in the alignment
marked by asterisks were selected for further mutant characterization in Fig. 2 and are color coded according to
representations in (c) and (d). The location of the RHH secondary structure in RelB is depicted by a black arrow and grey
boxes, respectively. (c) Side view of a structure model of the RelB–DNA complex based on the NMR structure of RelB1–50
(PDB ID 2k29) and the crystal structure of the Arc–DNA complex (PDB ID 1bdt). Two RelB1–50 dimers were modeled on a
22-nucleotide double-stranded fragment representing Arc operator DNA. RelB1–50 monomers of each dimer are colored
green and red or yellow and blue, respectively. Side chains of the conserved R7 amino acid (grey spheres) from the β-
strand of each subunit make sequence-specific base interactions in DNA major grooves. Side chains of the conserved S28
(cyan spheres) from the N-terminal part of helix α2 make unspecific DNA sugar–phosphate backbone interactions. Side
chains of K13 (magenta spheres) from the N-terminal part of helix α1 make putative electrostatic DNA sugar–phosphate
backbone interactions. (d) Side view of (c) by 90° rotation along the y-axis. The representations were prepared in
PyMOL.37
185Regulatory Interactions of RelBN-terminal domain,34 the Arc–DNA crystal struc-
ture,39,40,41 and our previous published stoichiomet-
ric data33 (Fig. 1c and d). In themodel, two important
sets of protein–DNA contacts are observed: β-sheets
that insert into the DNA major grooves making
crucial sequence-specific nucleotide base contacts
(S3, D5 andR7) and protein–DNAbackbone contacts
involving amino acids in the N-terminus of the
second α-helix α2 (S28). We obtained mutations in
S28 (S28F and S28H) that abolished autoregulation,
which could indicate that protein backbone amide
groups in combination with side-chain specific
hydrogen bonds make crucial contacts with the
DNA phosphate groups on either side of the majorgrooves (Fig. 1c and d). In addition, we obtained
K13E substitutions. Lysine 13 is a surface-exposed
basic residue that potentially can form additional
nonspecific contact through electrostatic interaction
to the DNA backbone phosphate on both sides of the
DNA helix (Fig. 1d). This interaction might, in
combination with the contacts made by S28, guide
or anchor the RelB dimers for correct positioning and
sequence-specific nucleotide base contacts between
the antiparallel β-sheets of RelB and the DNA major
grooves in the operator region. Yet other mutations
in relB yielded amino acid changes in key residues of
the hydrophobic core in the RHH domain that
probably do not contribute directly to protein–
186 Regulatory Interactions of RelBDNA contacts (i.e., I8, L33 and I38). Another
substitution, which maps to the α1–α2 loop
(V25G), could potentially affect DNA binding by
changing the relative position of α1 to α2 crucial
for anchoring DNA backbone contacts by the N-
terminus of helix α2.
DNA-binding properties of RelB with amino acid
changes in the RHH motif
The above-described amino acid changes in RelB
in all cases abolished autoregulation of the relBE
operon. To gain direct evidence for defects in relO
operator binding, we analyzed the autoregulatory
and DNA-binding properties of RelB RHH variants
R7A, I8A, K13A and S28L/R (Fig. 1b, asterisks). In
the first three RelB variants, we introduced a single
alanine substitution such that the properties of
specific residues could be compared. For S28 we
chose to create two substitutions (S28L, S28R). In the
dimeric Arc repressor, homologous replacements
(S35L, S35R) disrupt cooperative DNA binding41
(see the Discussion). The transcriptional activity of
the relBE promoter was measured using a series of
relBER81A-lacZ transcriptional fusion constructs
based in an R1 low-copy-number transcriptional
fusion plasmid (Fig. 2a). As in the genetic screening,
the RelB RHH variants were coexpressed with
nontoxic RelER81A encoded in cis (Fig. 2a). While
wild-type (WT) RelB efficiently repressed the
promoter to below 10 U, the RHH mutations R7A,
S28L and S28R all resulted in more than 100-fold
derepression. The I8A and K13Amutants resulted in
43- and 83-fold derepression, respectively (Fig. 2a).
Next, we measured DNA binding of the RelB
RHH variants in complex with the co-repressor
His6-RelE (RelE) in a gel-shift assay (Fig. 2b). The
antitoxin variants copurified with RelE and behavedRelB2·RelE complex or the mutant derivatives as indicated a
scanning.similar to WT RelB2·RelE with respect to tight
interaction with the toxin (see also Fig. 5). In the
gel-shift assay, a ternary complex of RelB2·-
RelE·relO166 formed at the lowest concentration
(0.05 μM) of protein (Fig. 2b). No ternary complexes
were observed for the RHH variants R7A, K13A and
S28L, not even at the highest concentration of the
protein complex (1.25 μM). Replacing I8 with an
alanine lowered the affinity of the RelB2·RelE
complex by ∼10- to 20-fold. For the S28R variant,
a faint ternary complex was only visible at the
highest concentration used (1.25 μM). The oligo-
meric states of WT RelB and the mutated variants
were further compared using chemical cross-linking
with BS3 [bis(sulfosuccinimidyl) suberate] (Fig. S1).
All RHH mutant proteins exhibited oligomerization
patterns similar to that of WT RelB. The most
predominant bands corresponded to dimers and
tetramers. At lower RelB concentrations, only the
dimeric band was observed (data not shown).
Interestingly, in the homologous dimeric Arc re-
pressor, S35 (S28 in RelB) is located in the dimer–
dimer interface and replacement to residues with
larger side chains (e.g., arginine or leucine) disrupts
cooperative binding.41 In summary, our DNA-
binding assays, structural model and cross-linking
data indicated that S28 is involved in DNA–backbone
interactions and is not required for tetramerization
of RelB.
Scanning mutagenesis of relO
Previously, RelB2 and the RelB2·RelE complexwere
found to protect a region within PrelBE termed relO
spanning the region −10 to +17 with respect to the
transcription start site.33 We confirmed that the left
and right boundaries of the operator were located
around −10 and +20 by 5′ and 3′ promoter–operatorFig. 2. In vivo and in vitro
characterization of amino acid
changes in the RHH motif of RelB.
(a) Autoregulation of relBE RHH
mutants. Strains carrying plasmid
derivatives of the low-copy-number
R1 transcriptional fusion relBER81A::
lacZ vector, pMGJ4004, with the
relB mutations indicated, were
grown exponentially in LB medium
and subjected to β-galactosidase
assay. Each value represents the
mean of at least three independent
experiments. Error bars represent
standard deviation of the mean. (b)
Gel-shift analysis of RelB2·RelE re-
pression complexes carrying sub-
stitutions in the DNA-binding RHH
domain of RelB. A Cy5-labeled PCR
fragment (relO166) was incubated in
the absence (−) or presence of
increasing concentrations (0.05,
0.25 and 1.25 μM) of either WT
nd subjected to native PAGE and subsequent fluorescent
187Regulatory Interactions of RelBDNAdeletion analysis using gel-shift assays (Fig. S2a
and b).
To further define the sequence specificity required
for high-affinity binding of RelB2·RelE to relO, we
systematically introduced dinucleotide transversion
substitutions in the promoter–operator region from
−10 to +16 (Fig. 3, relO1 through relO14). These
mutations were introduced into R1 lacZ transcrip-
tional fusion vectors containing either the entire
relBER81A operon (pMGJ4004, repressed promoter)
or only the relB promoter as a control for promoter
activity (pKG4001, unrepressed promoter). Thus,
the control plasmid was used to assess the effect of
the mutations on the activity of the unrepressed
relBE promoter (data not shown). The transcriptional
activity of each promoter construct was measured
during exponential cell growth. Mutations between
positions −10 and −7 (TA and CT introduced into
the −10 box) abolished PrelBE promoter activity of the
control plasmid and excluded them from the
analysis. For the remaining constructs, the transcrip-
tional activities of the repressed promoters (due to
the presence of relBER81A) were normalized with theFig. 3. Scanning mutagenesis of relO. A series of dinucleoti
(relO13 and relO14) and insertions (relO15 and relO16) were in
transformed into strain MG1 (ΔrelBEF::aphA) and cultures we
galactosidase assay. Each value represents the mean of at least
galactosidase activity of the unrepressed mutant promoter
represent standard deviation of the mean. A double-stranded
The hexad repeats of each operator half-site are boxed in red a
Fig. 4 are marked by black bars.activity of the unrepressed promoter (see Materials
and Methods). Full repression of PrelBE was defined
as the LacZ activity expressed from a plasmid
(pMGJ4001) carrying the WT operator, relO (5.2±
2.4 U). Mutations on both sides of the pseudo
palindromic half-site (TTGTAATGACAT) TG→GT,
TA→GC (relO1 and relO2) and GA→TC, CA→AC
(mutants relO4 and relO5 in Fig. 3) resulted in signi-
ficant derepression (12- and 36-fold, respectively),
whereas the central AT (relO3) appeared less critical
for repression. A similar pattern was observed for
the perfect palindromic right half-site TTGTAAT-
TACAA, with the exception of the first TG dinucle-
otide (relO7), which appeared to be more important
than any other dinucleotide pair. Interestingly,
substitution of the central TT pair resulted in a
190-fold derepression of transcription that may
reflect the loss of RelB2·RelE binding to both half-
sites of relO (relO6). To determine the contribution of
each of the central T's, we extended the analysis and
introduced single base transversions (relO13 and
relO14). In these cases, the promoter was dere-
pressed 5- and 4-fold, respectively, indicating thatde substitutions (relO1 to relO12), single base substitutions
troduced into pMGJ4004 and the resulting plasmids were
re grown exponentially in LB medium and subjected to β-
three independent experiments normalized to the LacZ β-
relative to the corresponding WT promoter. Error bars
representation of relO is given at the bottom of the figure.
nd blue, respectively, and protected positions obtained in
Fig. 4. Hydroxyl radical footprinting of relO166. PCR
fragments of relO166,
32P-end-labeled at the top and
bottom strands, respectively, were incubated in the
absence (−) or presence of increasing concentrations (0.1,
0.5 and 2.5 μM) of RelB2 or RelB2·RelE complex and
subjected to hydroxyl radical footprinting. A ladder of G+
A of each DNA fragment was included next to the foot-
printing reactions. Black bars indicate DNA sugar–
backbone protected positions along relO, which are also
indicated in Fig. 3.
188 Regulatory Interactions of RelBthe boundary between the two half-sites plays a
pivotal role in maintaining cooperativity between
adjacent bound RelB2·RelE complexes, possibly
involving DNA bending similar as shown for the
Arc repressor–DNA complex (Fig. 1c and d).
The above-described and previous findings
showed that both half-sites of relO were required
for cooperative binding of the RelB2·RelE
complexes.33,34 Therefore, we introduced spacing
between the two half-sites. Addition of only two
nucleotides (relO15) that brought the two half-sites
out of phase resulted in 45-fold derepression of relBE
transcription. Insertion of eight additional T nucleo-
tides (relO16) brought the half-sites back into phase;
however, it failed to restore repression (50-fold
derepression). Thus, the architecture of the RelB2·
RelE complex bound to operator DNA requires both
half-sites in close proximity. The mutational analysis
of relO defined a hexad binding motif [A/T]TGT[A/
C]A, repeated twice on each strand (Fig. 3, bottom),
with the less critical nucleotide being the terminal A
nucleotide of each subsite.
RelB occupies four distinct subsites in relO
Next, we performed hydroxyl radical footprinting
on both DNA strands of relO using increasing
concentrations of RelB and RelB2·RelE complexes
(Fig. 4). Two discrete but distinct regions of
protection (marked with filled bars) were observed
for the two highest concentrations of RelB and for all
three concentrations of the RelB2·RelE complex,
confirming that RelB interacts directly with relO
and that RelE acts to increase its affinity. This
pattern was evident for both strands (Fig. 4, left and
right). However, closer examination of these regions
on both strands revealed that DNA backbone
protection occurs at two base positions, T and G in
one of the protected regions and at three base
positions T, T and G in the other region. The
strongest protection occurred at the backbone of the
guanine base. These distinct sites confirmed the
subtle asymmetry of the two half-sites and further
define a relO core sequence of [a/t]TGt[a/c]a
(Fig. 3). More importantly, the protected regions
on each strand were interrupted by 9 and 10 bp,
respectively, without any protection. This observa-
tion indicated that relO was occupied by two RelB
dimers on the same face of the DNA, thus support-
ing the model shown in Fig. 1c and d.
RelB forms a tight 2:1 heterotrimeric complex
with RelE
RelE increased both the affinity (N10-fold) and the
cooperativity of RelB dimers for relO.33,34 Using
quantitative immunoblotting, we estimated that
there are 550 to 1100 RelB and 50 to 100 RelE
molecules in rapidly growing cells of MG1655
carrying WT relBE at its native chromosomal locus
(Fig. S3). These measurements were difficult to
accomplish due to the low cellular amounts of the
proteins, and, to our knowledge, this is the firstestimate of the levels of a toxin–antitoxin pair
expressed in its native context. RelB was in ≈10-
fold excess of RelE. This relatively modest excess of
RelB can keep RelE inactivated only if RelB binds
very tightly to RelE. To address this question
quantitatively, we measured the affinity of the
RelB–RelE interaction by surface plasmon resonance
(SPR) analysis. To this end, we immobilized RelB-
Cys on an SPR sensor chip (the extra cysteine in RelB
did not change the interaction with RelE; see
Materials and Methods). To determine the kinetics
of the interaction, RelE was injected over the chip
surface containing immobilized RelB-Cys. The result
of repeated cycles of association, dissociation and
regeneration using increasing concentrations is
shown (Fig. 5a). The binding response data were
fitted to an equation (Langmuir, Materials and
Methods) to obtain estimates for the rate constants
Fig. 5. Kinetic and stoichiometric measurements of
RelB and RelE interactions. (a) SPR kinetic analysis. Forty
resonance units (RU) of RelB-Cys was immobilized on a
CM5 sensor chip and assayed for concentration-depen-
dent RelE binding. Increasing concentrations of RelE were
injected in separate association/dissociation/regeneration
cycles performed in duplicate for each concentration used.
The reference-subtracted response difference in reso-
nance units (RU) for each concentration used is shown
in the sensorgram. RelE concentrations from top to bottom:
100, 50, 25, 12.5 and 0 nM. Dashed lines indicate fitted
values used to obtain the rate constants (see the text). (b)
Tryptophan fluorescence analysis of the RelB–RelE inter-
action. Complex formation was monitored by stoichio-
metric titration of RelE (0.35 μM) with RelB. RelE
tryptophans were excited at 295 nm, and the emission
signal was monitored from 315 to 400 nm. The maxima
values at approximately 330 nm are represented as
fractional change. Each point represents the average of
four measurements. Error bars represents the standard
deviation.
189Regulatory Interactions of RelBkon (5.01×10
5 M−1 s−1) and koff (1.66×10
− 4 s−1). The
apparent dissociation constant Kd (koff/kon) of
0.33 nM was similar to the strong binding affinities
reported for other TA systems.42,43 As described in
the Supplemental Material, these data allowed us to
estimate that, on average, there is less than one free
RelE molecule per cell in rapidly growing cells.
Recently, we reported that RelB and RelE form a
RelB2·RelE complex,
33 whereas data obtained else-
where favored a RelB2·RelE2 complex.
34 To obtain
more information on the stoichiometry of theRelB·RelE complex in solution, we measured trypto-
phan fluorescence of RelE (RelB does not contain
tryptophan) upon titration with RelB (Fig. 5b). As
shown, the increase in fluorescence upon complex
formation leveled off at a RelB/RelE ratio of ∼2. This
result supports the formation of a (RelB2·RelE)n
complex. To obtain more independent estimates of
the stoichiometry, we also performed amino acid
analysis of purified RelB·RelE complex (Table S2),
whichwaspreformed in vivo (SupplementalMaterial).
The experimentally determined number of residues
were clearly in favor of a 2:1 ratio of RelB/RelE.
RelB displays functional interaction with Lon
The ATP-dependent protease Lon degrades RelB
in vivo.2 To analyze the RelB–Lon interaction, we
performed SPR analysis of the purified proteins.
Injection of Lon-His6 (Lon) over a chip surface
containing immobilized RelB-Cys resulted in a
binding response with a slow dissociation phase
(Fig. 6a). This interaction was further stimulated by
including the Lon cofactors, ATP and Mg2+, in the
buffer. Interestingly, removal of ATP and Mg2+
resulted in fast dissociation of additional bound Lon
back to the level obtained without the addition of
cofactors. A weak stimulatory effect of Mg2+ alone
was detected (data not shown). This indicates that
most of the effect observed when including ATP and
Mg2+ in the buffer can be ascribed to ATP.
To determine the kinetic constants of the interac-
tion, increasing concentrations of Lon were injected
over the sensor chip surface containing immobilized
RelB-Cys (Fig. 6b). The rate constant koff was quite
low (2.34×10− 4 s−1) but we failed to obtain a reliable
fit for the association rate constant kon. Nevertheless,
we estimate the apparent dissociation constant Kd to
be less than 2 nM.
Finally, we investigated the functionality of the
interaction between Lon and RelB using an in vitro
degradation assay. Here we used a RelB variant
containing anN-terminal tag for heart myosin kinase
(HMK-RelB) to allow 32P labeling of the protein for
detection of full-length RelB as well as possible
degradation products in a quantitative manner.
Incubation of Lon with HMK-RelB resulted in
degradation of HMK-RelB in an ATP- and Mg2+-
dependent manner (Fig. 6c, lanes 1–4). Prior forma-
tion of a complex between HMK-RelB and RelE
reduced the degradation rate (Fig. 6c, lane 5). The
in vitro half-life of HMK-RelB was long (N60 min)
(Fig. 6c, lanes 7–12). Since the degradation rate slowed
significantly after 60 min, this could reflect either
depletion of ATP or inactivation of Lon. We did not
obtain any effects of including an ATP regeneration
system or by using native RelB (data not shown).Discussion
RelB is the crucial regulator of themodel relBE locus.
Therefore, we investigated in detail the molecular
interactions of the RelB antitoxin with respect to (i) the
Fig. 6. RelB is degraded by Lon protease. (a and b) SPR analysis. RelB-Cys was immobilized on a CM5 sensor chip and
Lon was injected at a concentration of 200 nM with (red sensorgram) or without (blue sensorgram) MgCl2 (8 mM) and
ATP (2 mM) in the buffer as indicated by arrows in the figure. At time ∼450 s, the dissociation phase was initiated with
(red sensorgram) or without (blue line) MgCl2 and ATP in the buffer. Finally, a second dissociation phase at time ∼550 s
was initiated by changing to buffer without MgCl2 and ATP (red sensorgram only). For kinetic measurements, the
following Lon concentrations were used: from top to bottom, 100, 50 nM, 25 nM, 12.5 and 0 nM. (c) In vitro degradation of
HMK-RelB. Lon and 32P[HMK-RelB] were incubated at 37 °C for 120 min (lanes 1–5) or the times indicated (lanes 6–12) in
reaction buffer with or without the components specified and subjected to SDS-PAGE and phosphoimaging. In control
reactions (lanes 1 and 6) Lon was omitted.
190 Regulatory Interactions of RelBrelO operator DNA, (ii) interaction with RelE and (iii)
interaction with the ATP-dependent protease Lon.
To delineate the RelB DNA binding and/or co-
repressor interaction space, we used mutagenic PCR
to obtain relBmutants that, when cloned in our lacZ
reporter system (Fig. 1), conferred derepression of
the relBE promoter. The amino acid changes in RelB
mapped to distinct and important domains within
the N-terminal DNA-binding RHHmotif.34,44 At the
β-stranded N-terminus forming an antiparallel β-
sheet with a second RelB monomer (Fig. 1c and d),
we obtained a mutation of isoleucine I8 into a
threonine. Together with the conserved hydropho-
bic amino acids I4 and L6, this residue constitutes an
important element of the hydrophobic core of the
RHH domain. In chemical cross-linking assays, the
RelBI8A mutant formed dimeric and tetrameric
species, similar to WT RelB (Fig. S1). By inference,
I8 probably plays a more direct role in DNA
interaction, since its multimerization properties
appeared similar to those of WT RelB. Consistently,
NMR titration studies of RelB revealed major
chemical shift perturbations of I8 upon binding to
operator DNA.34
Unexpectedly, the β-strand residues N5 and R7
that are engaged in nucleotide base specific
contacts34 were not obtained in the screen. We
therefore constructed the RelBR7A variant and
thereby confirmed the importance of this basic
residue in our in vitro and in vivo operator-binding
assays (Fig. 2).The DNA binding surface of RelB displays an
overall positive electrostatic potential, which is
primarily maintained by residues R7 and K13.
Several mutants obtained in our screen resulted in
the RelBK13E variant, indicating the importance of
the charge contribution from this residue. According
to the RelB–DNAmodel, K13 side chains are in close
proximity to the DNA phosphate backbone on
either side of DNA (Fig. 1d), implying potential
electrostatic backbone contacts. In addition, K13
displays major chemical shift perturbations upon
binding to operator DNA.34
In RHH proteins, β-sheet binding to DNA major
groove by nucleotide base specific contacts are
assisted by further nonspecific contacts to the DNA
phosphate backbone.44 These contacts are made
specifically by protein-backbone amide nitrogen
atoms at the N-terminus of helix α2. We also
obtained mutations in S28 of RelB (S28F/H) in our
screen and S28L/R changes introduced by site-
directed mutagenesis affected operator binding and
relBE autoregulation, as expected (Fig. 2). In the
crystal structure of CopG bound to DNA, hydrogen
bonds between side chains of S29 at the N-terminus
of helix α2 and phosphate groups of DNA further
sustain this backbone interaction45 and thus provide
a possible explanation for the conservation of serine
or threonine residues at this position. Finally, the
S28L/RRelBmutants formeddimeric and tetrameric
species in chemical cross-linking assays (Fig. S1).
This indicates that unlike similar amino acid
191Regulatory Interactions of RelBchanges in the dimer–dimer interface of Arc
repressor (S35L/R) defective in cooperative opera-
tor binding, RelB tetramerization includes addi-
tional contacts, which potentially could involve the
flexible C-terminus.34,41
In the loop region between helices α1 and α2, the
conserved G-X-S/T/N motif is critical for the
correct positioning of the N-terminus of helix α2
to make anchoring contacts to the DNA phosphate
backbone.44 Consistently, a V25G mutation led to
promoter derepression (Fig. 1b) and a site-directed
G24P mutation resulted in a hyperlabile RelB
mutant defective in autoregulation and operator
binding (data not shown). Taken together, our
genetic approach was very useful in the construc-
tion of RelB mutants, since we picked up amino
acid changes in most of the signature residues
within the RHH DNA-binding domain.
Recently, we showed that RelB in complex with
RelE binds cooperatively to separate half-sites in
relO, suggesting that two RelB2·RelE heterotrimers
occupy both sites simultaneously.33 Interaction
occurred exclusively via RelB, as RelE alone or in
complex with RelB did not alter the DNase I
protection pattern. Here we performed a mutational
analysis of the relO operator to determine nucleotide
bases within the operator half-sites critical for
specific binding of RelB dimers. We found, with a
resolution of two nucleotides, that the central four
nucleotides within the hexad core sequence [A/T]
TGT[A/C]A are highly critical for autorepression
(Fig. 3). In addition, we found that no spacing could
be accommodated between the two 12-bp pseudo
palindromic and perfect palindromic half-sites,
which is in accordance with a cooperative binding
mode. Consistently, RelB and the RelB2·RelE com-
plex confer hydroxyl radical backbone protection at
TG and TTG sequences in the left and right half-
sites, respectively (Figs 3 and 4).
Previous studies showed that free RelE inhibits
protein synthesis by inducing cleavage of mRNAs
positioned in the ribosomal A-site.5 This activity of
RelE is counteracted by direct protein–protein
interaction to antitoxin RelB.5,31 The interaction
between RelB and RelE depends on the flexible
and proteolytically cleavable C-terminus of RelB.46
We obtained estimates of the kinetic rate constants
of the RelB–RelE interaction (Fig. 5), which con-
firmed that RelB and RelE form a highly stable
complex with an in vitro half-life of approximately
70 min. Based on our estimates of the total cellular
amounts of RelB and RelE (Fig. S3) and our SPR
interaction data, we estimated that the cellular level
of free RelE is probably lower than one molecule per
cell. This low level must be due to both the negative
transcriptional control loop and the tight complex
formation between RelB and RelE. Since over-
expression of RelE very efficiently inhibits transla-
tion,30,31 the level of free RelE must be very low in
rapidly growing cells and our estimate is thus
consistent with this inference.
In agreement with previously published results,33
our data obtained here favor a stoichiometry of 2:1 forthe RelB–RelE complex (Fig. 5b and Table S2). In two
separate studies, analytical gel-filtration analysis
determined the mass of the RelB·RelE complex to
be 47 and 49 kDa, respectively.34,46 This is close to the
calculated mass of a (RelB·RelE)2 heterotetramer.
Indeed, a heterotetramer was obtained in the crystal
structure of an archaeal RelB·RelE complex.18 In
support of a 2:1 stoichiometry,we have analytical gel-
filtration data that show that free RelE is a monomer
(data not shown), and from chemical cross-linking
we have evidence that RelB forms dimers and
tetramers in solution (Fig. S1). This is in agreement
with additional analysis using differential scanning
calorimetry (Fig. S4). Thus, our data favor a RelB2·
RelE complex as the major species in solution.
However, TA stoichiometries are highly dynamic
and interconversion between heterotrimer and het-
erotetramer species allows for increased capacity of
the antitoxin to neutralize its cognate toxin and also
provides a mechanism for TA ratio-dependent
derepression of their cognate promoters.33,47,48 We
suggested previously that RelB2·RelE is the primary
repressor complex that binds at relO and that excess
RelE leads to the formation of a RelB2·RelE2 complex
that does not bind to relO, thereby explaining
mechanistically how excess of RelE derepresses
relBE transcription.33
Activation of RelE is achieved through ATP-
dependent RelB degradation by the Lon protease.2,23
Here we provide direct evidence for a strong
interaction between Lon and RelB in vitro (Fig. 6a).
Moreover, we found that the interaction was en-
hanced byATP and to a lesser degree bymagnesium.
The nature of this interaction is not known; however,
overexpression of a proteolytically inactive Lon
mutant sequesters efficiently Lon substrates and
thereby complements the mutant phenotypes of a
lon mutant.49 Thus, initial substrate binding is
important for Lon function and is in good agreement
with the stable complexes we obtained using SPR
analysis. We also confirmed that Lon degrades RelB
in vitro in amagnesium- andATP-dependentmanner
(Fig. 6b). This degradation is likely to be initiated at
the proteolytically unstable C-terminus of RelB that is
protected by RelE.46 Prior formation of RelB2·RelE
complexes by addition of a molar excess of RelE
reduced degradation, consistent with the proposal
that RelE interacts with the C-terminus of RelB and
thereby protects RelB from degradation by Lon.
In this study, we have characterized multiple
important molecular interactions within the RelBE
system in E. coli: interaction of RelB with RelE,
preventing its mRNA interferase activity and essen-
tial for efficient autoregulation; interaction of RelB
with Lon, regulating its metabolic turnover and
activation of RelE; interaction of RelB with relO
DNA, required for autoregulation of the relBE operon.
Combined, these interactions keep the system in the
OFF-state during steady-state growth along with a
derepressor mechanism and translational coupling
ensuring RelB is kept in excess to RelE (Christensen
and Gerdes, unpublished data). Upon nutritional
stress, such as amino acid starvation, relBE is
192 Regulatory Interactions of RelBactivated and reduces the global rate of translation.2
Shortly after onset of starvation, theRelB/RelE ratio is
reduced. This change leads to release of the RelB2–
RelE complex and derepression of the strong relBE
promoter. Unfortunately, we do not have direct
evidence for the notion that this trigger mechanism
is important for the biological function of relBE.
However, the trigger mechanism is conserved in
nonhomologous TA loci,15,47,50,51,52 arguing that
indeed it is important. One function may be to
promote rapid induction of relBE transcription at the
onset of nutritional stress such as amino acid
starvation. The regulatory interactions with the
RelBE system are summarized in the model shown
in Fig. 7 and further explained in the figure legend.
The biological function of chromosomal TA loci
is currently a matter of debate. However, accumu-
lating evidence suggests that at least some of them
function to adjust the global rates of translation and
replication to a given supply of nutrients from the
environment.1 Accordingly, in support of the stress
response hypothesis, transcription of a number of
TA loci was induced by heat shock in Sulfolobus
sulfataricus53 and by exposure to chloroform in
Nitrosomonas europaea.54Materials and Methods
Media, antibiotics, strains and plasmids
Luria–Bertani (LB) and 2×YTmediumwere prepared as
described.55 When required, LB broth or LB plates were
supplemented with ampicillin (30 or 100 μg/ml; Amp). X-
gal was added to indicator plates to a final concentrationpressor RelE. The repression complex bound to its operator o
transcription initiation of RNA polymerase and results in a low
induced growth arrest, the ATP-dependent protease Lon degra
and in complex with RelE. A reduction in the global rate
equilibrium toward free RelE as the level of RelB declines.
derepression of the promoter due to loss of cooperativity
contribute to a decrease in the RelB/RelE ratio in concert with e
target, the ribosomal A-site, to promote codon-specific cleava
the cell and may yield a lower level of translation errors.of 40 μg/ml. Expression of proteins from the pA1/O4/O3
or pBAD promoters was induced by 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) or 0.2% arabinose, respec-
tively. Strains and plasmids are listed in Table 1. The
Top10 strain was used as the standard host strain for
cloning and the resulting plasmids were subsequently
transformed into relevant strain backgrounds.Mutagenic PCR and cassette mutagenesis
To synthesize DNA fragments carrying random muta-
tions between codon 4 and codon 75 of relB, 0.1 mM
MnCl2 was added to an otherwise standard Taq PCR
reaction containing primers relB-mut-BamHI-f and relB-
mut-XbaI-r using pMO2541 as template. The resulting
PCR fragment (∼0.23 kb) was inserted into BamHI–XbaI-
digested pMO2541 vector and ligated. pMO2541 and its
mutant derivatives were plated onto LB agar+Amp
(30 μg/ml)+X-gal (40 μg/ml) and screened for dark
blue (derepressed) colonies among a background of pale
colonies (repressed).Protein expression and purification
The RelB His6–RelE complex formed in vivo, RelB (WT
and mutant alleles) and His6-RelE proteins were purified
using the strains and plasmids indicated in Table 1 and
according to the protocol described previously.58 Lon-
His6 was purified from strain LVM781/pBAD24-lon-his6.
Briefly, a 5-ml overnight culture was diluted into 1 L of
2×YT medium containing ampicillin (100 mg/ml; Amp)
and was cultured at 30 °C. At OD450 ∼0.5, the expression
was induced by arabinose for 3 h. The culture was
harvested by centrifugation and resuspended in ice-cold
buffer A (50 mM NaH2PO4, 0.3 M NaCl, 10 mM
imidazole, 5 mM β-mercaptoethanol, pH 8). The cellsFig. 7. Model explaining regu-
lation of the relBE locus. The relBE
operon has a typical TA organiza-
tion. The first gene encodes the RelB
antitoxin (green) and the second
gene encodes mRNA interferase
and co-repressor RelE (red). RelB
is produced in ∼10 fold excess of
RelE due to coupled translation
(bent arrow, +). RelB monomers
readily form dimers via their N-
terminal RHH domain and interact
with RelE monomers to form a tight
nontoxic complex. During exponen-
tial growth, RelE is exclusively
bound by RelB. This complex
forms a heterohexamer when
bound to relO, which involves
cooperativity mediated by co-re-
verlapping the −10 box in the promoter region prevents
level of relBE expression. In steady-state and upon stress
des RelB at a high rate. Lon degrades RelB in its free states
of translation as a consequence of stress shifts the RelE
This shift in the ratio between RelB and RelE results in
in the repression complex. Increased transcription may
nhanced activity of Lon. As a result RelE is free to act on its
ge of mRNA. This in turn reduces energy consumption in
Table 1. Bacterial strains and plasmids used in this study
Strains/plasmids Genotype Source/reference
Strains
MG1655 Wild-type E. coli 56
MG1 MC1000ΔrelBEF::kan 2
SC34 MG1655ΔrelBEF 36
SG22095 Δlac rcsA166ΔaphA lon146::tet Susan Gottesman
LVM781 F−mcrAΔ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 deoR
recA1 araD139 Δ(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG λ−
L. Van Melderen
Top10 BL21(DE3) mutant strain Invitrogen
C41 (DE3) Wild-type E. coli 57
Plasmids
pSC2524 pMG25, PA1/O4/O3::SDopt::relB:: SDopt::his6::relE Laboratory collection
pMO207 pMG25, PA1/O4/O3::SDopt::hmk-relB:: SDopt::his6::relE This work
pMO213 pMG25, PA1/O4/O3::SDopt::relB-cys:: SDopt::his6::relE This work
pOU253 Mini-R1, bla, lacZYA, translational fusion vector Laboratory collection
pKG4001 pOU254, bla, relB 5′::lacZYA 19
pMO2534 pOU253, bla, relBE::lacZYA This work
pMO2535 pOU253, bla, relBER81A::lacZYA This work
pMO2540 pOU253, bla, BamHI-relB-XbaI-relE-KpnI::lacZYA This work
pMO2541 pOU253, bla, BamHI-relB-XbaI-relER81A-KpnI::lacZYA This work
pMGJ4004 pOU254, bla, relO(WT), relBER81A::lacZYA This work
pMO259 pOU254, bla, relO1, relBER81A::lacZYA This work
pMO277 pOU254, bla, relO1, relB 5′::lacZYA This work
pMO260 pOU254, bla, relO2, relBER81A::lacZYA This work
pMO278 pOU254, bla, relO2, relB 5′::lacZYA This work
pMO261 pOU254, bla, relO3, relBER81A::lacZYA This work
pMO279 pOU254, bla, relO3, relB 5′::lacZYA This work
pMO262 pOU254, bla, relO4, relBER81A::lacZYA This work
pMO280 pOU254, bla, relO4, relB 5′::lacZYA This work
pMO263 pOU254, bla, relO5, relBER81A::lacZYA This work
pMO281 pOU254, bla, relO5, relB 5′::lacZYA This work
pMO264 pOU254, bla, relO6, relBER81A::lacZYA This work
pMO282 pOU254, bla, relO6, relB 5′::lacZYA This work
pMO265 pOU254, bla, relO7, relBER81A::lacZYA This work
pMO283 pOU254, bla, relO7, relB 5′::lacZYA This work
pMO266 pOU254, bla, relO8, relBER81A::lacZYA This work
pMO284 pOU254, bla, relO8, relB 5′::lacZYA This work
pMO267 pOU254, bla, relO9, relBER81A::lacZYA This work
pMO285 pOU254, bla, relO9, relB 5′::lacZYA This work
pMO268 pOU254, bla, relO10, relBER81A::lacZYA This work
pMO286 pOU254, bla, relO10, relB 5′::lacZYA This work
pMO269 pOU254, bla, relO11, relBER81A::lacZYA This work
pMO287 pOU254, bla, relO11, relB 5′::lacZYA This work
pMO270 pOU254, bla, relO12, relBER81A::lacZYA This work
pMO288 pOU254, bla, relO12, relB 5′::lacZYA This work
pMO271 pOU254, bla, relO13, relBER81A::lacZYA This work
pMO289 pOU254, bla, relO13, relB 5′::lacZYA This work
pMO272 pOU254, bla, relO14, relBER81A::lacZYA This work
pMO290 pOU254, bla, relO14, relB 5′::lacZYA This work
pMO273 pOU254, bla, relO15, relBER81A::lacZYA This work
pMO291 pOU254, bla, relO15, relB 5′::lacZYA This work
pMO274 pOU254, bla, relO16, relBER81A::lacZYA This work
pMO292 pOU254, bla, relO16, relB 5′::lacZYA This work
pMO237 pMG25, PA1/O4/O3::SDopt::relB
R7A:: SDopt::his6::relE This work
pMO238 pMG25, PA1/O4/O3::SDopt::relB
I8A:: SDopt::his6::relE This work
pMO239 pMG25, PA1/O4/O3::SDopt::relB
K13A:: SDopt::his6::relE This work
pMO240 pMG25, PA1/O4/O3::SDopt::relB
S28L:: SDopt::his6::relE This work
pMO241 pMG25, PA1/O4/O3::SDopt::relB
S28R:: SDopt::his6::relE This work
pMO244 pOU254, bla, relBR7ArelER81A::lacZYA This work
pMO245 pOU254, bla, relBI8ArelER81A::lacZYA This work
pMO246 pOU254, bla, relBK13ArelER81A::lacZYA This work
pMO249 pOU254, bla, relBS28LrelER81A::lacZYA This work
193Regulatory Interactions of RelBwere disrupted by passing them three times through a
French press cell and the soluble fraction was isolated by
centrifugation at 48,400g for 30 min. The cleared lysate
was incubated with Ni–NTA agarose resin (Qiagen) in
batches according to manufacturer instructions and
subsequently loaded onto a gravity flow column at
4 °C. The Ni–agarose resin was washed extensively in
buffer B (50 mM NaH2PO4, 1 M NaCl, 60 mM imidazole,
1 mM β-mercaptoethanol, pH 8). Finally, Lon-His6 waseluted in buffer B and 250 mM imidazole and diluted
threefold before dialysis storage buffer [50 mM Tris
(pH 7.5), 0.2 M KCl, 1 mM ethylenediaminetetraacetic
acid (EDTA), 10% glycerol, 1 mM DTT].
Each purified protein was at least 95% pure as estimated
by silver staining of SDS-PAGE gels. The molecular
masses of all proteins used in this study were verified by
matrix-assisted laser-desorption/ionization time-of-flight
mass spectrometry.
194 Regulatory Interactions of RelBβ-Galactosidase assay
Activity of the various relBE-lacZ derivatives listed in
Table 1 was measured according to Miller59 and as
described previously.33Electrophoretic mobility shift assay and hydroxyl
radical footprinting
Gel-shift assays were carried out using the protocol
described previously.33
Hydroxyl radical footprinting was carried out essen-
tially according to Tullius et al.60 Primer labeling (32P),
PCR and binding reactions were prepared as described.33
Each binding reaction was made in a total volume of 35 μl.
To initiate generation of hydroxyl radicals and, thus, DNA
backbone cleavage, 5 μl of a freshly prepared mixture of
0.1 mM (NH4)2Fe(SO4)2·6H2O and 0.2 mM EDTA was
deposited on the inner wall of an Eppendorf tube along
with 5 μl of 0.6% H2O2 and 5 μl of sodium ascorbate
(10 mM). The cutting reagents were mixed with the
protein–DNA solution and incubated at 37 °C for 1 min.
The reaction was stopped by the addition of 21 μl of stop
solution (23.8 mM thiourea, 152 mM EDTA, 0.2 mg/ml
salmon sperm DNA, 2% glycerol). The resulting fragmen-
ted DNA was extracted once in phenol and once in
chloroform, precipitated and washed in ethanol and
separated on 6% denaturing acrylamide gels along with
a G+A sequencing ladder (see below). The gel was dried
and finally subjected to phosphoimaging using a Typhoon
Trio scanner (GE Healthcare).Maxam–Gilbert G+A sequencing
Radiolabeled PCR (100 nM) was chilled on ice for 5 min
with 4 μg of sheared salmon sperm (ss) DNA in a total
volume of 24 μl. To the sample was then added 4 μl of
piperidine formate (1 M, pH 2) and incubated at 37 °C for
15 min. The reaction was terminated by the adding 240 μl
of stop reagent (0.3 M sodium acetate, pH 7) and the DNA
was precipitated by adding 750 μl of 96% ethanol, chilled
at −80 °C for 10 min and collected by centrifugation. The
latter step was repeated twice, once with 0.1 M sodium
acetate (pH 4.5) and once in 96% ethanol. Then 100 μl of
piperidine (1 M) was added to the DNA pellet and
incubated at 90 °C for 30 min. The DNA solution was
snap-frozen in liquid nitrogen and dried in a speed-vac
overnight. Finally, the pellet was resuspended in 10 μl of
water and dried in a speed-vac twice and resuspended in
80% formamide loading buffer. Sequencing reactions were
separated alongside the corresponding hydroxyl radical
reactions as described above.Surface plasmon resonance analysis
SPR analyses of RelB–RelE and RelB–Lon interactions
were carried out on a Biacore 3000 instrument (Biacore
AB) equipped with a CM5 sensor chip. In short,
Approximately 40 RU RelB-Cys was immobilized with
ligand thiol coupling [4 min NHS/EDC, 4 min PDEA,
short pulses of RelB-Cys in 10 mMNaAc (pH 3.5), reduced
and desalted on Poros R1, 4 min cysteine]. His6-RelE or
Lon-His6 at concentrations (monomeric) indicated in the
figure was injected over immobilized RelB-Cys in series
with a nonderivatized reference control flow cell at a flow
rate of 60 μl/min. After each injection, RelE/Lon wasreleased from the surface by two consecutive 30-s
injections of 3 M guanidine HCl in 50% running buffer
(HBS-EP: 10 mM Hepes, 150 mM NaCl, 0.005% Tween 20,
3 mM EDTA, pH 7.4). The response of the reference flow
cell was subtracted from the response of the RelB-Cys flow
cell and then from the response of a buffer injection. In
order to obtain the rate constants, double reference
subtracted sensorgrams were fitted (least sum of squared
residuals) to a model of 1:1 binding (Langmuir binding)
using the BIAevaluation 3.1 software package. Calcula-
tions of stoichiometry were carried out as described.33
Tryptophan fluorescence measurements
Fluorescence experiments were carried out using an LS
55 fluorescence spectrometer (Perkin Elmer) at 25 °C.
Tryptophan fluorescence of His6-RelE protein (0.35 μM)
was measured before and after addition of increasing
molar amounts of RelB. All titrations were performed in
phosphate-buffered saline (pH 7.4). Complexes were
allowed to form by gently mixing the components for
5 min in the cuvette with the aid of a small stir bar.
Emission spectra were taken from 315 to 400 nm with
excitation at 295 nm using a slit width of 10 nm. Data were
collected by integration of five consecutive scans at a scan
speed of 900 nm/min. Each data point represents the peak
value (at approximately 330 nm) for the mean of five scans
expressed as fractional change.
Lon/RelB degradation assay
Tomonitor the degradation of RelB, the ATP-dependent
protease Lon (0.6 μM) was added to a reaction buffer
[50mMTris–HCl (pH 8), 4mMATP, 7.5mMMgCl2]. Prior
to the experiments, HMK-RelB was labeled with 32P on the
N-terminal HMK-tag (RRASV) using the PKAce kit
(Novagen) according to the manufacturer's instructions.
Formation of complexes between HMK-RelB and His6-
RelE was achieved by preincubating 0.13 μM HMK-RelB
with 0.52 μMHis6-RelE at ambient temperature for 20min.
HMK-RelB (0.13 μM), free or in complex,was finally added
to the reaction mixture in a final volume of 20 μl and
incubated at 37 °C for the times indicated in the figure.
Degradation was stopped by adding SDS-loading buffer
and boiling of the samples for 5 min at 95 °C. The proteins
were separated by SDS-PAGEusing 16%Tris–tricine gels61
and visualized by phosphoimaging of the dried gels.
Modeling of the RelB–DNA complex
Modelling of RelB–DNA was done using structures of
the N-terminal domain of RelB (RelB1–50) [Protein Data
Bank (PDB) code 2k29] and of the Arc–DNA complex
(PDB 1bdt) as template. The backbone of the RelB1–50
dimer was superimposed onto the template RHH dimer
structure by using the VMD plugin multiseq.Acknowledgements
We thank Peter Højrup for performing amino acid
analysis, PiaHovendal andTorbenKibøl for excellent
technical assistance, Jacob Pøhlsgaard for modeling
the RelB–DNA complex, and members of the Loris
195Regulatory Interactions of RelBand Gerdes groups for stimulating discussions. We
also thank Susan Gottesman for the donation of
strains. This work was supported by The Danish
National Research Foundation via Centre for mRNP
Biogenesis and Metabolism and the Wellcome Trust.Supplementary Data
Supplementary data associated with this article
can be found, in the online version, at doi:10.1016/
j.jmb.2009.09.006
References
1. Gerdes, K., Christensen, S. K. & Lobner-Olesen, A.
(2005). Prokaryotic toxin–antitoxin stress response
loci. Nat. Rev. Microbiol. 3, 371–382.
2. Christensen, S. K., Mikkelsen, M., Pedersen, K. &
Gerdes, K. (2001). RelE, a global inhibitor of transla-
tion, is activated during nutritional stress. Proc. Natl
Acad. Sci. USA, 98, 14328–14333.
3. Van Melderen, L., Bernard, P. & Couturier, M. (1994).
Lon-dependent proteolysis of CcdA is the key control
for activation of CcdB in plasmid-free segregant
bacteria. Mol. Microbiol. 11, 1151–1157.
4. Kamada, K. & Hanaoka, F. (2005). Conformational
change in the catalytic site of the ribonuclease YoeB
toxin by YefM antitoxin. Mol. Cell, 19, 497–509.
5. Pedersen, K., Zavialov, A. V., Pavlov, M. Y., Elf, J.,
Gerdes, K. & Ehrenberg, M. (2003). The bacterial toxin
RelE displays codon-specific cleavage of mRNAs in
the ribosomal A site. Cell, 112, 131–140.
6. Zhang, Y. L., Zhang, J. J., Hoeflich, K. P., Ikura, M.,
Qing, G. L. & Inouye, M. (2003). MazF cleaves cellular
mRNAs specifically at ACA to block protein synthesis
in Escherichia coli. Mol. Cell, 12, 913–923.
7. Munoz-Gomez, A. J., Santos-Sierra, S., Berzal-Herranz,
A., Lemonnier, M. & Diaz-Orejas, R. (2004). Insights
into the specificity of RNA cleavage by the Escherichia
coli MazF toxin. FEBS Lett. 567, 316–320.
8. Christensen-Dalsgaard, M. & Gerdes, K. (2006). Two
higBA loci in the Vibrio cholerae superintegron encode
mRNA cleaving enzymes and can stabilize plasmids.
Mol. Microbiol. 62, 397–411.
9. Bernard, P. & Couturier, M. (1992). Cell killing by the
F-plasmid Ccdb protein involves poisoning of DNA-
topoisomerase-II complexes. J. Mol. Biol. 226, 735–745.
10. Jiang, Y., Pogliano, J., Helinski, D. R. & Konieczny, I.
(2002). ParE toxin encoded by the broad-host-range
plasmid RK2 is an inhibitor of Escherichia coli gyrase.
Mol. Microbiol. 44, 971–979.
11. Miki, T., Park, J. A., Nagao, K., Murayama, N. &
Horiuchi, T. (1992). Control of segregation of chro-
mosomal DNA by sex factor F in Escherichia coli
mutants of DNA gyrase subunit A suppress letD
(ccdB) product growth inhibition. J. Mol. Biol. 225,
39–52.
12. Dao-Thi, M. H., Charlier, D., Loris, R., Maes, D.,
Messens, J., Wyns, L. & Backmann, J. (2002). Intricate
interactions within the ccd plasmid addiction system.
J. Biol. Chem. 277, 3733–3742.
13. Lah, J., Marianovsky, I., Glaser, G., Engelberg-Kulka,
H., Kinne, J., Wyns, L. & Loris, R. (2003). Recognition
of the intrinsically flexible addiction antidote MazE by
a dromedary single domain antibody fragment—
structure, thermodynamics of binding, stability, andinfluence on interactions with DNA. J. Biol. Chem, 278,
14101–14111.
14. Lah, J., Simic, M., Vesnaver, G., Marianovsky, I.,
Glaser, G., Engelberg-Kulka, H. & Loris, R. (2005).
Energetics of structural transitions of the addiction
antitoxin MazE—is a programmed bacterial cell death
dependent on the intrinsically flexible nature of the
antitoxins? J. Biol. Chem. 280, 17397–17407.
15. Madl, T., Van Melderen, L., Mine, N., Respondek, M.,
Oberer, M., Keller, W. et al. (2006). Structural basis for
nucleic acid and toxin recognition of the bacterial
antitoxin CcdA. J. Mol. Biol. 364, 170–185.
16. Kamada, K., Hanaoka, F. & Burley, S. K. (2003). Crystal
structure of theMazE/MazF complex:Molecular bases
of antidote–toxin recognition. Mol. Cell, 11, 875–884.
17. Loris, R., Marianovsky, I., Lah, J., Laeremans, T.,
Engelberg-Kulka, H., Glaser, G. et al. (2003). Crystal
structure of the intrinsically flexible addiction antidote
MazE. J. Biol. Chem. 278, 28252–28257.
18. Takagi, H., Kakuta, Y., Okada, T., Yao, M., Tanaka, I.
& Kimura, M. (2005). Crystal structure of archaeal
toxin–antitoxin RelE–RelB complex with implications
for toxin activity and antitoxin effects.Nat. Struct. Mol.
Biol. 12, 327–331.
19. Gotfredsen, M. &Gerdes, K. (1998). The Escherichia coli
relBE genes belong to a new toxin–antitoxin gene
family. Mol. Microbiol. 29, 1065–1076.
20. Marianovsky, I., Aizenman, E., Engelberg-Kulka, H.
& Glaser, G. (2001). The regulation of the Escherichia
coli mazEF promoter involves an unusual alternating
palindrome. J. Biol. Chem. 276, 5975–5984.
21. Tam, J. E. & Kline, B. C. (1989). Control of the Ccd
operon in plasmid-F. J. Bacteriol. 171, 2353–2360.
22. Aizenman, E., Engelberg-Kulka, H. & Glaser, G.
(1996). An Escherichia coli chromosomal “addiction
module” regulated by guanosine [corrected] 3′,5′-
bispyrophosphate: a model for programmed bacterial
cell death. Proc. Natl Acad. Sci. USA, 93, 6059–6063.
23. Christensen, S. K. & Gerdes, K. (2004). Delayed-
relaxed response explained by hyperactivation of
RelE. Mol. Microbiol. 53, 587–597.
24. Christensen, S. K., Maenhaut-Michel, G., Mine, N.,
Gottesman, S., Gerdes, K. & Van, M. L. (2004).
Overproduction of the Lon protease triggers inhibi-
tion of translation in Escherichia coli: involvement of
the yefM–yoeB toxin–antitoxin system.Mol. Microbiol.
51, 1705–1717.
25. Lehnherr, H. & Yarmolinsky, M. B. (1995). Addiction
protein Phd of plasmid prophage P1 is a substrate of
the Clpxp serine-protease of Escherichia-coli. Proc. Natl
Acad. Sci. USA, 92, 3274–3277.
26. VanMelderen, L., Thi, M. H. D., Lecchi, P., Gottesman,
S., Couturier, M. & Maurizi, M. R. (1996). ATP-
dependent degradation of CcdA by Lon protease—
effects of secondary structure andheterologous subunit
interactions. J. Biol. Chem. 271, 27730–27738.
27. Lehnherr, H.,Maguin, E., Jafri, S. &Yarmolinsky,M. B.
(1993). Plasmid addiction genes of bacteriophage-P1-
Doc, which causes cell-death on curing of prophage,
and Phd, which prevents host death when prophage is
retained. J. Mol. Biol. 233, 414–428.
28. Roberts, R. C. & Helinski, D. R. (1992). Definition of a
minimal plasmid stabilization system from the broad-
host-range plasmid Rk2. J. Bacteriol. 174, 8119–8132.
29. Ruiz-Echevarria, M. J., de la Cueva, G. & Diaz-Orejas,
R. (1995). Translational coupling and limited degra-
dation of a polycistronic messenger modulate diffe-
rential gene expression in the parD stability system of
plasmid R1. Mol. Gen. Genet. 248, 599–609.
196 Regulatory Interactions of RelB30. Christensen, S. K. & Gerdes, K. (2003). RelE toxins
from bacteria and Archaea cleave mRNAs on trans-
lating ribosomes, which are rescued by tmRNA. Mol.
Microbiol. 48, 1389–1400.
31. Pedersen, K., Christensen, S. K. & Gerdes, K. (2002).
Rapid induction and reversal of a bacteriostatic
condition by controlled expression of toxins and
antitoxins. Mol. Microbiol. 45, 501–510.
32. Galvani, C., Terry, J. & Ishiguro, E. E. (2001).
Purification of the RelB and RelE proteins of Escherichia
coli: RelE binds to RelB and to ribosomes. J. Bacteriol.
183, 2700–2703.
33. Overgaard, M., Borch, J., Jorgensen, M. G. & Gerdes,
K. (2008). Messenger RNA interferase RelE controls
relBE transcription by conditional cooperativity. Mol.
Microbiol. 69, 841–857.
34. Li, G. Y., Zhang, Y., Inouye, M. & Ikura, M. (2008).
Structural mechanism of transcriptional autorepres-
sion of the Escherichia coli RelB/RelE antitoxin/toxin
module. J. Mol. Biol. 380, 107–119.
35. Zhao, X. Y. & Magnuson, R. D. (2005). Percolation of
the Phd repressor–operator interface. J. Bacteriol. 187,
1901–1912.
36. Christensen, S. K., Pedersen, K., Hansen, F. G. &
Gerdes, K. (2003). Toxin–antitoxin loci as stress-
response-elements: ChpAK/MazF and ChpBK cleave
translated RNAs and are counteracted by tmRNA.
J. Mol Biol. 332, 809–819.
37. DeLano,W. L. (2002). The PyMOLMolecular Graphics
System. DeLANO Scientific, Palo Alto, CA. USA.
Available at http://www.pymol.org.
38. Diderichsen, B., Fiil, N. P. & Lavalle, R. (1977).
Genetics of the relB locus in Escherichia coli. J. Bacteriol.
131, 30–33.
39. Bonvin, A. M., Vis, H., Breg, J. N., Burgering, M. J.,
Boelens, R. & Kaptein, R. (1994). Nuclear magnetic
resonance solution structure of the Arc repressor
using relaxation matrix calculations. J. Mol. Biol. 236,
328–341.
40. Raumann, B. E., Rould,M.A., Pabo, C.O.& Sauer, R. T.
(1994). DNA recognition by beta-sheets in the arc
repressor–operator crystal-structure. Nature, 367,
754–757.
41. Smith, T. L. & Sauer, R. T. (1995). P22 arc repressor—
role of cooperativity in repression and binding to
operators with altered half-site spacing. J. Mol. Biol.
249, 729–742.
42. Dao-Thi, M. H., Van Melderen, L., De Genst, E., Afif,
H., Buts, L., Wyns, L. & Loris, R. (2005). Molecular
basis of gyrase poisoning by the addiction toxin CcdB.
J. Mol. Biol. 348, 1091–1102.
43. Khoo, S. K., Loll, B., Chan,W. T., Shoeman, R. L., Ngoo,
L., Yeo, C. C. & Meinhart, A. (2007). Molecular and
structural characterization of the PezAT chromosomal
toxin–antitoxin system of the human pathogen Strep-
tococcus pneumoniae. J. Biol. Chem. 282, 19606–19618.
44. Schreiter, E. R. & Drennan, C. L. (2007). Ribbon–helix–
helix transcription factors: variations on a theme. Nat.
Rev. Microbiol. 5, 710–720.
45. Gomis-Ruth, F. X., Sola, M., Acebo, P., Parraga, A.,
Guasch, A., Eritja, R. et al. (1998). The structure of
plasmid-encoded transcriptional repressor CopG
unliganded and bound to its operator. EMBO J. 17,
7404–7415.46. Cherny, I., Overgaard, M., Borch, J., Bram, Y., Gerdes,
K. & Gazit, E. (2007). Structural and thermodynamic
characterization of the Escherichia coli RelBE toxin–
antitoxin system: indication for a functional role of
differential stability. Biochemistry, 46, 12152–12163.
47. Monti, M. C., Hernandez-Arriaga, A. M., Kamphuis,
M. B., Lopez-Villarejo, J., Heck, A. J. R., Boelens, R.
et al. (2007). Interactions of Kid–Kis toxin–antitoxin
complexes with the parD operator–promoter region of
plasmid R1 are piloted by the Kis antitoxin and tuned
by the stoichiometry of Kid–Kis oligomers. Nucleic
Acids Res. 35, 1737–1749.
48. Buts, L., Lah, J., Dao-Thi, M. H., Wyns, L. & Loris, R.
(2005). Toxin–antitoxinmodules as bacterial metabolic
stress managers. Trends Biochem. Sci. 30, 672–679.
49. Van Melderen, L. & Gottesman, S. (1999). Substrate
sequestration by a proteolytically inactive Lonmutant.
Proc. Natl Acad. Sci. USA, 96, 6064–6071.
50. Afif, H., Allali, N., Couturier, M. & Van Melderen, L.
(2001). The ratio between CcdA and CcdB modulates
the transcriptional repression of the ccd poison–
antidote system. Mol. Microbiol. 41, 73–82.
51. Johnson, E. P., Strom, A. R. & Helinski, D. R. (1996).
Plasmid RK2 toxin protein ParE: purification and
interaction with the ParD antitoxin protein. J. Bacteriol.
178, 1420–1429.
52. Magnuson, R. & Yarmolinsky, M. B. (1998). Core-
pression of the P1 addiction operon by Phd and Doc.
J. Bacteriol. 180, 6342–6351.
53. Tachdjian, S. & Kelly, R.M. (2006). Dynamicmetabolic
adjustments and genome plasticity are implicated in
the heat shock response of the extremely thermoaci-
dophilic Archaeon Sulfolobus solfataricus. J. Bacteriol.
188, 4553–4559.
54. Gvakharia, B. O., Permina, E. A., Gelfand, M. S.,
Bottomley, P. J., Sayavedra-Soto, L. A. & Arp, D. J.
(2007). Global transcriptional response of Nitrosomo-
nas europaea to chloroform and chloromethane. Appl.
Environ. Microbiol. 73, 3440–3445.
55. Sambrook, J. & Russell, D. (2001).Molecular Cloning. A
Laboratory Manual. Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY.
56. Guyer, M. S., Reed, R. R., Steitz, J. A. & Low, K. B.
(1981). Identification of a sex-factor-affinity site inE. coli
as gamma delta. Cold Spring Harbor Symp. Quant. Biol.
45(Pt. 1), 135–140.
57. Miroux, B. & Walker, J. E. (1996). Over-production of
proteins in Escherichia coli: mutant hosts that allow
synthesis of some membrane proteins and globular
proteins at high levels. J. Mol. Biol. 260, 289–298.
58. Christensen-Dalsgaard, M., Overgaard, M., Winther,
K. S. & Gerdes, K. (2008). RNA decay by messenger
RNA interferases. Methods Enzymol. 447, 521–535.
59. Miller, J. H. (1972). Experiments in Molecular Genetics.
Cold Spring Harbor Laboratory Press, Cold Spring
Harbor.
60. Tullius, T. D., Dombroski, B. A., Churchill, M. E. &
Kam, L. (1987). Hydroxyl radical footprinting: a high-
resolution method for mapping protein–DNA con-
tacts. Methods Enzymol. 155, 537–558.
61. Schägger, H. & von Jagow, G. (1987). Tricine-sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
for the separation of proteins in the range from 1 to
100 kDa. Anal. Biochem. 166, 368–379.
